Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication

Ayumi Kudoh, Masatoshi Fujita, Tohru Kiyono, Kiyotaka Kuzushima, Yutaka Sugaya, Shunji Izuta, Yukihiro Nishiyama, Tatsuya Tsurumi

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Productive infection and replication of herpesviruses usually occurs in growth-arrested cells, but there has been no direct evidence in the case of Epstein-Barr virus (EBV), since an efficient lytic replication system without external stimuli does not exist for the virus. Expression of the EBV lytic-switch transactivator BZLF1 protein in EBV-negative epithelial tumor cell lines, however, is known to arrest the cell cycle in G0/G1 by induction of the tumor suppressor protein p53 and the cyclin-dependent kinase (CDK) inhibitors p21WAF-1/CIP-1 and p27KIP-1, followed by the accumulation of a hypophosphorylated form of the Rb protein. In order to determine the effect of the onset of lytic viral replication on cellular events in latently EBV-infected B LCLs, a tightly controlled induction system of the EBV lytic-replication program by inducible BZLF1 protein expression was established in B95-8 cells. The induction of lytic replication completely arrested cell cycle progression and cellular DNA replication. Surprisingly, the levels of p53, p21WAF-1/CIP-1, and p27KIP-1 were constant before and after induction of the lytic program, indicating that the cell cycle arrest induced by the lytic program is not mediated through p53 and the CDK inhibitors. Furthermore, although cellular DNA replication was blocked, elevation of cyclin E/A expression and accumulation of hyperphosphorylated forms of Rb protein were observed, a post-G1/S phase characteristic of cells. Thus, while the EBV lytic program promoted specific cell cycle-associated activities involved in the progression from G1 to S phase, it inhibited cellular DNA synthesis. Such cellular conditions appear to especially favor viral lytic replication.

Original languageEnglish
Pages (from-to)851-861
Number of pages11
JournalJournal of virology
Volume77
Issue number2
DOIs
Publication statusPublished - Jan 1 2003
Externally publishedYes

Fingerprint

Human herpesvirus 4
cyclin-dependent kinase
Cyclin-Dependent Kinases
DNA replication
DNA Replication
Human Herpesvirus 4
S Phase
interphase
B-lymphocytes
B-Lymphocytes
Retinoblastoma Protein
Cell Cycle Checkpoints
Cell Cycle
cell cycle
Tumor Suppressor Protein p53
Herpesviridae Infections
Cyclin E
Trans-Activators
G1 Phase
Virus Replication

All Science Journal Classification (ASJC) codes

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. / Kudoh, Ayumi; Fujita, Masatoshi; Kiyono, Tohru; Kuzushima, Kiyotaka; Sugaya, Yutaka; Izuta, Shunji; Nishiyama, Yukihiro; Tsurumi, Tatsuya.

In: Journal of virology, Vol. 77, No. 2, 01.01.2003, p. 851-861.

Research output: Contribution to journalArticle

Kudoh, Ayumi ; Fujita, Masatoshi ; Kiyono, Tohru ; Kuzushima, Kiyotaka ; Sugaya, Yutaka ; Izuta, Shunji ; Nishiyama, Yukihiro ; Tsurumi, Tatsuya. / Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. In: Journal of virology. 2003 ; Vol. 77, No. 2. pp. 851-861.
@article{b22c5afb3764498bb4cc9c3b2a0f2322,
title = "Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication",
abstract = "Productive infection and replication of herpesviruses usually occurs in growth-arrested cells, but there has been no direct evidence in the case of Epstein-Barr virus (EBV), since an efficient lytic replication system without external stimuli does not exist for the virus. Expression of the EBV lytic-switch transactivator BZLF1 protein in EBV-negative epithelial tumor cell lines, however, is known to arrest the cell cycle in G0/G1 by induction of the tumor suppressor protein p53 and the cyclin-dependent kinase (CDK) inhibitors p21WAF-1/CIP-1 and p27KIP-1, followed by the accumulation of a hypophosphorylated form of the Rb protein. In order to determine the effect of the onset of lytic viral replication on cellular events in latently EBV-infected B LCLs, a tightly controlled induction system of the EBV lytic-replication program by inducible BZLF1 protein expression was established in B95-8 cells. The induction of lytic replication completely arrested cell cycle progression and cellular DNA replication. Surprisingly, the levels of p53, p21WAF-1/CIP-1, and p27KIP-1 were constant before and after induction of the lytic program, indicating that the cell cycle arrest induced by the lytic program is not mediated through p53 and the CDK inhibitors. Furthermore, although cellular DNA replication was blocked, elevation of cyclin E/A expression and accumulation of hyperphosphorylated forms of Rb protein were observed, a post-G1/S phase characteristic of cells. Thus, while the EBV lytic program promoted specific cell cycle-associated activities involved in the progression from G1 to S phase, it inhibited cellular DNA synthesis. Such cellular conditions appear to especially favor viral lytic replication.",
author = "Ayumi Kudoh and Masatoshi Fujita and Tohru Kiyono and Kiyotaka Kuzushima and Yutaka Sugaya and Shunji Izuta and Yukihiro Nishiyama and Tatsuya Tsurumi",
year = "2003",
month = "1",
day = "1",
doi = "10.1128/JVI.77.2.851-861.2003",
language = "English",
volume = "77",
pages = "851--861",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication

AU - Kudoh, Ayumi

AU - Fujita, Masatoshi

AU - Kiyono, Tohru

AU - Kuzushima, Kiyotaka

AU - Sugaya, Yutaka

AU - Izuta, Shunji

AU - Nishiyama, Yukihiro

AU - Tsurumi, Tatsuya

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Productive infection and replication of herpesviruses usually occurs in growth-arrested cells, but there has been no direct evidence in the case of Epstein-Barr virus (EBV), since an efficient lytic replication system without external stimuli does not exist for the virus. Expression of the EBV lytic-switch transactivator BZLF1 protein in EBV-negative epithelial tumor cell lines, however, is known to arrest the cell cycle in G0/G1 by induction of the tumor suppressor protein p53 and the cyclin-dependent kinase (CDK) inhibitors p21WAF-1/CIP-1 and p27KIP-1, followed by the accumulation of a hypophosphorylated form of the Rb protein. In order to determine the effect of the onset of lytic viral replication on cellular events in latently EBV-infected B LCLs, a tightly controlled induction system of the EBV lytic-replication program by inducible BZLF1 protein expression was established in B95-8 cells. The induction of lytic replication completely arrested cell cycle progression and cellular DNA replication. Surprisingly, the levels of p53, p21WAF-1/CIP-1, and p27KIP-1 were constant before and after induction of the lytic program, indicating that the cell cycle arrest induced by the lytic program is not mediated through p53 and the CDK inhibitors. Furthermore, although cellular DNA replication was blocked, elevation of cyclin E/A expression and accumulation of hyperphosphorylated forms of Rb protein were observed, a post-G1/S phase characteristic of cells. Thus, while the EBV lytic program promoted specific cell cycle-associated activities involved in the progression from G1 to S phase, it inhibited cellular DNA synthesis. Such cellular conditions appear to especially favor viral lytic replication.

AB - Productive infection and replication of herpesviruses usually occurs in growth-arrested cells, but there has been no direct evidence in the case of Epstein-Barr virus (EBV), since an efficient lytic replication system without external stimuli does not exist for the virus. Expression of the EBV lytic-switch transactivator BZLF1 protein in EBV-negative epithelial tumor cell lines, however, is known to arrest the cell cycle in G0/G1 by induction of the tumor suppressor protein p53 and the cyclin-dependent kinase (CDK) inhibitors p21WAF-1/CIP-1 and p27KIP-1, followed by the accumulation of a hypophosphorylated form of the Rb protein. In order to determine the effect of the onset of lytic viral replication on cellular events in latently EBV-infected B LCLs, a tightly controlled induction system of the EBV lytic-replication program by inducible BZLF1 protein expression was established in B95-8 cells. The induction of lytic replication completely arrested cell cycle progression and cellular DNA replication. Surprisingly, the levels of p53, p21WAF-1/CIP-1, and p27KIP-1 were constant before and after induction of the lytic program, indicating that the cell cycle arrest induced by the lytic program is not mediated through p53 and the CDK inhibitors. Furthermore, although cellular DNA replication was blocked, elevation of cyclin E/A expression and accumulation of hyperphosphorylated forms of Rb protein were observed, a post-G1/S phase characteristic of cells. Thus, while the EBV lytic program promoted specific cell cycle-associated activities involved in the progression from G1 to S phase, it inhibited cellular DNA synthesis. Such cellular conditions appear to especially favor viral lytic replication.

UR - http://www.scopus.com/inward/record.url?scp=0037219580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037219580&partnerID=8YFLogxK

U2 - 10.1128/JVI.77.2.851-861.2003

DO - 10.1128/JVI.77.2.851-861.2003

M3 - Article

C2 - 12502801

AN - SCOPUS:0037219580

VL - 77

SP - 851

EP - 861

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 2

ER -